Quick filters:
Open Data
Open Code
Pre-registered
Funding Declared
COI Declared
Open Access
Clear Filters
Addition of plerixafor in poorly mobilized allogeneic stem cell donors.
J Clin Apher
(Unknown)
Published: 2022
Impact of Covid-19 on the therapeutic plasma exchange service within the South East Asian region: Consensus recommendat…
Viswanathan S; Hiew FL; Siritho S; Apiwattanakul M; Tan K; Quek AML; Estiasari R; Remli R; Bhaskar S; Islam BM; Aye SMM; Ohnmar O; Umapathi T; Keosodsay SS; Hoang NTT; Yeo T; Pasco PM.
J Clin Apher
(Unknown)
Published: 2021
A matched cohort study of convalescent plasma therapy for COVID-19.
J Clin Apher
(Unknown)
Published: 2021
Direct hemoperfusion using a polymyxin B-immobilized polystyrene column for COVID-19.
Katagiri D; Ishikane M; Asai Y; Izumi S; Takasaki J; Katsuoka H; Kondo I; Ide S; Nakamura K; Nakamoto T; Nomoto H; Akiyama Y; Miyazato Y; Suzuki T; Kinoshita N; Ogawa T; Togano T; Suzuki M; Hashimoto M; Sakamoto K; Kusaba Y; Katsuno T; Fukaya T; Hojo M; Sugiyama M; Mizokami M; Okamoto T; Kimura A; Noiri E; Ohmagari N; Hinoshita F; Sugiyama H.
J Clin Apher
(Unknown)
Published: 2020
Convalescent plasma therapy in patients with COVID-19.
Yiğenoğlu TN; Hacıbekiroğlu T; Berber İ; Dal MS; Baştürk A; Namdaroğlu S; Korkmaz S; Ulas T; Dal T; Erkurt MA; Turgut B; Altuntaş F.
J Clin Apher
(Unknown)
Published: 2020
How do people become plasma and platelet donors in a VNR context?
J Clin Apher
(Unknown)
Published: 2017